Vivos (RDGL) EBIT Margin Growth (1y) (2011 - 2025)
Vivos (RDGL) EBIT Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 146.00 |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | 882,246.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 882,246.00 |
| Sep 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -62,952.00 |
| Mar 31, 2025 | 959,669.00 |
| Sep 30, 2024 | -703,957.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -868,646.00 |
| Sep 30, 2023 | -556,079.00 |
| Jun 30, 2023 | -656,741.00 |
| Mar 31, 2023 | 161,131.00 |
| Sep 30, 2022 | -295,547.00 |
| Sep 30, 2021 | 52,779.00 |
| Sep 30, 2020 | 575,523.00 |
| Mar 31, 2017 | 783,957.00 |
| Sep 30, 2016 | -1.40 Mn |
| Mar 31, 2016 | -1.41 Mn |
| Mar 31, 2015 | 115,500.00 |
| Mar 31, 2014 | 214,576.00 |
| Sep 30, 2013 | 307,091.00 |
| Mar 31, 2013 | -453,231.00 |